School of Pharmacy

Patients benefit best from medications when they take the right medicines at the right dose and at the right time.

While tailoring medications to a group's genetic ancestry can be important, scientists warn that these generalizations might also be misleading.

In the new United States Medicare Part D prescription drug plan, most people are responsible for 100% of their drug costs after their annual drug expenses exceed US$2,250 and until their expenses reach US$5,100.

Pamela M. England, PhD, UCSF School of Pharmacy faculty member and expert in the areas of neuroscience and memory formation, will receive one of four Technological Innovations in Neuroscience Awards for 2006-2008.

Darryl Inaba, PharmD, UCSF School of Pharmacy 1971 alumnus, a substance abuse expert and former CEO of the Haight Ashbury Free Clinics, Inc., was honored on August 7, 2006 as the clinics' first fellow.

Research studies can be designed to influence the results, comments Lisa Bero, PhD, UCSF School of Pharmacy faculty member and expert on industry sponsorship of research and conflict of interest.

Helene Levens Lipton, PhD, UCSF School of Pharmacy faculty member and health policy expert, comments that insurers will remain in the Medicare Part D marketplace as long as they benefit.

Candy Tsourounis, PharmD, UCSF School of Pharmacy clinical faculty member and expert on herbals and dietary supplements, warns that depending upon your blood cholesterol levels, a cholesterol-lowering dietary supplement might not be enough for you.

In light of the US Food and Drug Administration (FDA) July 31, 2006 announcement that it is proceeding to work toward making emergency contraception, known as Plan B, a non-prescription product for women ages 18 and older, two UCSF School of Pharmacy c

Christopher A. Voigt, PhD, UCSF School of Pharmacy scientist, and colleagues are engineering bacteria to target tumors and create images.